AR047483A1 - MULTI-VITAMIN AND MINERAL SUPPLEMENT FOR PREGNANT WOMEN - Google Patents
MULTI-VITAMIN AND MINERAL SUPPLEMENT FOR PREGNANT WOMENInfo
- Publication number
- AR047483A1 AR047483A1 ARP040101281A ARP040101281A AR047483A1 AR 047483 A1 AR047483 A1 AR 047483A1 AR P040101281 A ARP040101281 A AR P040101281A AR P040101281 A ARP040101281 A AR P040101281A AR 047483 A1 AR047483 A1 AR 047483A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical
- dietary
- vitamin
- woman
- pregnant
- Prior art date
Links
- 229940029985 mineral supplement Drugs 0.000 title 1
- 235000020786 mineral supplement Nutrition 0.000 title 1
- 235000020772 multivitamin supplement Nutrition 0.000 title 1
- 235000005911 diet Nutrition 0.000 abstract 8
- 230000000378 dietary effect Effects 0.000 abstract 6
- 235000007882 dietary composition Nutrition 0.000 abstract 4
- 229930003231 vitamin Natural products 0.000 abstract 3
- 235000013343 vitamin Nutrition 0.000 abstract 3
- 239000011782 vitamin Substances 0.000 abstract 3
- 229940088594 vitamin Drugs 0.000 abstract 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
- 230000037213 diet Effects 0.000 abstract 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 2
- 239000011707 mineral Substances 0.000 abstract 2
- 235000010755 mineral Nutrition 0.000 abstract 2
- 230000000474 nursing effect Effects 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 239000011573 trace mineral Substances 0.000 abstract 2
- 235000013619 trace mineral Nutrition 0.000 abstract 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 abstract 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 1
- 235000013734 beta-carotene Nutrition 0.000 abstract 1
- 239000011648 beta-carotene Substances 0.000 abstract 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 1
- 229960002747 betacarotene Drugs 0.000 abstract 1
- 229960002685 biotin Drugs 0.000 abstract 1
- 235000020958 biotin Nutrition 0.000 abstract 1
- 239000011616 biotin Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 229910052804 chromium Inorganic materials 0.000 abstract 1
- 239000011651 chromium Substances 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 229910052750 molybdenum Inorganic materials 0.000 abstract 1
- 239000011733 molybdenum Substances 0.000 abstract 1
- 229960003966 nicotinamide Drugs 0.000 abstract 1
- 235000005152 nicotinamide Nutrition 0.000 abstract 1
- 239000011570 nicotinamide Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 229910052711 selenium Inorganic materials 0.000 abstract 1
- 239000011669 selenium Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Pediatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Forma de dosificacion unitaria farmacéutica o dietética, que se puede tragar con facilidad, que consta esencialmente de vitaminas, minerales y oligoelementos recomendados para el consuma por mujeres embarazadas, mujeres lactantes o mujeres con potencial para parir, que están intentando quedar embarazadas, de ácido docosahexaenoico (DHA) y de un vehículo apropiado farmacéutica o dietéticamente. Reivindicacion 1: Una composicion farmacéutica o dietética en forma de una cápsula o tableta, un globulo o una pastilla rombica, que se puede tragar con facilidad, que consta de (a) una o más vitaminas, (b) uno o más minerales seleccionados entre el conjunto que consta de hierro, zinc y magnesio, (c) uno o más oligoelementos seleccionados entre el conjunto que consta de cromo, cobre, yodo, molibdeno y selenio, (d) DHA, y (e) un vehículo apropiado farmacéutica o dietéticamente. Reivindicacion 2: Una composicion farmacéutica o dietética de acuerdo con la reivindicacion 1, en la que las vitaminas (a) se seleccionan entre el conjunto que consta de beta-caroteno, vitamina B1, vitamina B2, vitamina B6, vitamina B12, vitamina C, vitamina D3, vitamina E, ácido folico, biotina y niacinamida. Reivindicacion 11: Una composicion farmacéutica o dietética de acuerdo con una cualquiera de las reivindicaciones precedentes, en la forma de una cápsula de gelatina oblonga que tiene las siguientes dimensiones; diámetro de 7 a 11 mm; y longitud de 21 a 26 mm. Reivindicacion 12: Un método de suplementar las necesidades dietéticas de una mujer embarazada, una mujer lactante o una mujer con potencial de parir, que está intentando quedar embarazada, comprendiendo dicho método administrar a la mujer una cantidad suplementadora de la dieta de una composicion farmacéutica o dietética de acuerdo con una cualquiera de las reivindicaciones precedentes. Reivindicacion 14: Uso de una composicion farmacéutica o dietética de acuerdo con una cualquiera de las reivindicaciones 1 a 11, para la preparacion de una forma de dosificacion unitaria farmacéutica o diet??tetica para suplementar las necesidades dietéticas de una mujer embarazada, un amujer lactante o una mujer con potencial para parir, que está intentando quedar embarazada.Unit dosage form pharmaceutical or dietary, which can be swallowed easily, consisting essentially of vitamins, minerals and trace elements recommended for consumption by pregnant women, nursing women or women with the potential to give birth, who are trying to get pregnant, docosahexaenoic acid (DHA) and an appropriate pharmaceutical or dietary vehicle. Claim 1: A pharmaceutical or dietary composition in the form of a capsule or tablet, a globulus or a rhombic tablet, which can be easily swallowed, consisting of (a) one or more vitamins, (b) one or more minerals selected from the set consisting of iron, zinc and magnesium, (c) one or more trace elements selected from the set consisting of chromium, copper, iodine, molybdenum and selenium, (d) DHA, and (e) an appropriate pharmaceutical or dietary vehicle . Claim 2: A pharmaceutical or dietary composition according to claim 1, wherein the vitamins (a) are selected from the set consisting of beta-carotene, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, Vitamin D3, vitamin E, folic acid, biotin and niacinamide. Claim 11: A pharmaceutical or dietary composition according to any one of the preceding claims, in the form of an oblong gelatin capsule having the following dimensions; diameter from 7 to 11 mm; and length from 21 to 26 mm. Claim 12: A method of supplementing the dietary needs of a pregnant woman, a breastfeeding woman or a woman with the potential to give birth, which said method comprises administering to the woman a supplementary amount of the diet of a pharmaceutical composition or diet according to any one of the preceding claims. Claim 14: Use of a pharmaceutical or dietary composition according to any one of claims 1 to 11, for the preparation of a pharmaceutical or dietary unit dosage form to supplement the dietary needs of a pregnant woman, a nursing infant or a woman with the potential to give birth, who is trying to get pregnant.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03008985 | 2003-04-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047483A1 true AR047483A1 (en) | 2006-01-25 |
Family
ID=33185851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101281A AR047483A1 (en) | 2003-04-17 | 2004-04-16 | MULTI-VITAMIN AND MINERAL SUPPLEMENT FOR PREGNANT WOMEN |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1617734A1 (en) |
| JP (1) | JP2006523642A (en) |
| KR (1) | KR20060004939A (en) |
| CN (1) | CN1774179A (en) |
| AR (1) | AR047483A1 (en) |
| AU (1) | AU2004229165A1 (en) |
| BR (1) | BRPI0409585A (en) |
| CA (1) | CA2522462A1 (en) |
| CL (1) | CL2004000813A1 (en) |
| EC (1) | ECSP056108A (en) |
| MX (1) | MXPA05010930A (en) |
| PE (1) | PE20040963A1 (en) |
| RU (1) | RU2005135565A (en) |
| TW (1) | TW200507877A (en) |
| WO (1) | WO2004091317A1 (en) |
| ZA (1) | ZA200506794B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
| EP1879586A1 (en) * | 2005-03-10 | 2008-01-23 | Sciele Pharma, Inc. | Nutritional preparations comprising folates and essential fatty acids |
| FR2902659A1 (en) | 2006-06-23 | 2007-12-28 | Pierre Fabre Medicament Sa | DHA ESTER AND ITS USE IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES |
| ES2362292B1 (en) * | 2009-12-11 | 2012-02-23 | Farmalider, S.A. | ORAL COMPOSITION SOLID PHARMACEUTICAL OR DIETARY SPECIFICALLY INDICATED FOR WOMEN MANAGER. |
| JP5717092B2 (en) * | 2011-03-03 | 2015-05-13 | 株式会社 メドレックス | External patch |
| WO2015167434A1 (en) * | 2014-04-28 | 2015-11-05 | Eduardo Fernandez | Compositions for nutritional supplementation |
| CN104970372A (en) * | 2014-10-27 | 2015-10-14 | 上海妈咪宝贝生物科技有限公司 | Vitamin and mineral tablets for pregnant woman and wet nurse |
| US20180368458A1 (en) * | 2016-02-17 | 2018-12-27 | Corr-Jensen Inc. | Time release vitamins and minerals in edible oils |
| NL2017219B1 (en) | 2016-07-22 | 2018-01-30 | Rousselot B V | Low cross-linking gelatine |
| US11083738B2 (en) | 2017-09-28 | 2021-08-10 | Natals, Inc. | Dietary nutrient compositions |
| CN108310010B (en) * | 2018-04-03 | 2021-01-12 | 中国科学院上海硅酸盐研究所 | Ion reagent for treating myocardial infarction and preparation method and application thereof |
| WO2021190988A1 (en) * | 2020-03-27 | 2021-09-30 | Dsm Ip Assets B.V. | Prenatal confectionery |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8403433A (en) * | 1984-11-09 | 1986-06-02 | Holland Melkunie | FOOD SUPPLY PREPARATION BASED ON MILK COMPONENTS. |
| GB9608719D0 (en) * | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
| EP0891719A1 (en) * | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
| GB9808579D0 (en) * | 1998-04-22 | 1998-06-24 | Novartis Nutrition Ag | Improvements in or relating to organic compounds |
| US6569857B1 (en) * | 1999-05-03 | 2003-05-27 | Drugtech Corporation | Dietary supplement |
| US7226916B1 (en) * | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
| EP1155620B1 (en) * | 2000-05-18 | 2005-08-10 | Q-mega healthcare A/S | Dietary supplement comprising vitamins, minerals and polyunsaturated fatty acids |
| US6436431B1 (en) * | 2001-07-02 | 2002-08-20 | Diane Wright Hoffpauer | Fortified rice bran food product and method for promoting cardiovascular health |
| US7704542B2 (en) * | 2001-09-12 | 2010-04-27 | Xanodyne Pharmaceuticals, Inc. | Vitamin/mineral compositions with DHA |
-
2004
- 2004-04-14 CN CNA2004800101967A patent/CN1774179A/en active Pending
- 2004-04-14 RU RU2005135565/13A patent/RU2005135565A/en not_active Application Discontinuation
- 2004-04-14 MX MXPA05010930A patent/MXPA05010930A/en not_active Application Discontinuation
- 2004-04-14 KR KR1020057019535A patent/KR20060004939A/en not_active Ceased
- 2004-04-14 JP JP2006505117A patent/JP2006523642A/en active Pending
- 2004-04-14 CA CA002522462A patent/CA2522462A1/en not_active Abandoned
- 2004-04-14 EP EP04727260A patent/EP1617734A1/en not_active Withdrawn
- 2004-04-14 BR BRPI0409585-5A patent/BRPI0409585A/en not_active IP Right Cessation
- 2004-04-14 AU AU2004229165A patent/AU2004229165A1/en not_active Abandoned
- 2004-04-14 WO PCT/EP2004/003913 patent/WO2004091317A1/en not_active Ceased
- 2004-04-15 PE PE2004000378A patent/PE20040963A1/en not_active Application Discontinuation
- 2004-04-15 CL CL200400813A patent/CL2004000813A1/en unknown
- 2004-04-16 AR ARP040101281A patent/AR047483A1/en not_active Application Discontinuation
- 2004-04-16 TW TW093110721A patent/TW200507877A/en unknown
-
2005
- 2005-08-24 ZA ZA200506794A patent/ZA200506794B/en unknown
- 2005-10-17 EC EC2005006108A patent/ECSP056108A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1774179A (en) | 2006-05-17 |
| CA2522462A1 (en) | 2004-10-28 |
| EP1617734A1 (en) | 2006-01-25 |
| WO2004091317A1 (en) | 2004-10-28 |
| ZA200506794B (en) | 2006-04-26 |
| JP2006523642A (en) | 2006-10-19 |
| CL2004000813A1 (en) | 2005-03-04 |
| PE20040963A1 (en) | 2005-01-05 |
| TW200507877A (en) | 2005-03-01 |
| ECSP056108A (en) | 2006-03-01 |
| AU2004229165A1 (en) | 2004-10-28 |
| MXPA05010930A (en) | 2005-11-25 |
| BRPI0409585A (en) | 2006-04-18 |
| RU2005135565A (en) | 2006-07-27 |
| KR20060004939A (en) | 2006-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bakaloudi et al. | Intake and adequacy of the vegan diet. A systematic review of the evidence | |
| da Silva et al. | Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis | |
| AR047483A1 (en) | MULTI-VITAMIN AND MINERAL SUPPLEMENT FOR PREGNANT WOMEN | |
| CN102246967B (en) | Normal full nutrient | |
| US20130017182A1 (en) | Multi-criteria optimized dietary supplement formulations | |
| NZ593506A (en) | Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health | |
| BRPI0509374A (en) | multivitamin and mineral nutritional supplements | |
| JP2002051732A5 (en) | ||
| JP2006523642A5 (en) | ||
| Jiménez et al. | Nutritional supplementation in pregnant, lactating women and young children following a plant-based diet: A narrative review of the evidence | |
| Wakeman | A review of the effects of oral contraceptives on nutrient status, with especial consideration to folate in UK | |
| Romeyn | Nutrition and HIV: a new model for treatment. Vitamins, minerals and trace elements | |
| Vastag | Nutrients for prevention: negative trials send researchers back to drawing board | |
| BR112014008876A2 (en) | fast-dissolving food supplements | |
| MX418137B (en) | SOFT GELATIN CAPSULE PREPARATIONS OF VITAMINS AND MINERALS COMPRISING VITAMIN C IN THE FORM OF AN ASCORBATE SALT | |
| Alfin-Slater et al. | Nutrition and the Adult: Micronutrients Volume 3B | |
| US20130115201A1 (en) | Fluid Supplement with Prenatal Vitamins | |
| de Winter et al. | New Dutch practice guideline for administration of vitamin K to full-term newborns | |
| Kumar | What role do vitamins and supplements play in maintaining good health?| Naya Google | |
| Hoh et al. | The concepts and necessity of preconception care for men | |
| TH78143A (en) | Multivitamin and mineral supplements for pregnant women | |
| Aşkar et al. | Bir nutrasötik olarak borun kemik metabolizması üzerine etkileri | |
| Podkolzina et al. | Analysis cost of treating vitamin deficiency in patients with coronary heart disease | |
| Jin et al. | Micronutrient intake and supplement usage of pregnant and lactating women in New Zealand | |
| Van Schoor | Supplements in pregnancy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |